Jobs / United States / Natera INC

Natera INC

Clinical Oncology Specialist , GI

Atlanta, GA; Nashville, TN Posted 2 months ago

Apply on company site ↗ Source: Company careers site Tailor my CV

Free account: one tailored CV and cover letter included. You always apply on the employer’s own page.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Natera INC paid sponsored hires in similar roles1 certified filing for “Clinical Lab Scientist I” (Medical and Clinical Laboratory Technologists) in CA: $86k–$86k, median $86k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Natera INC paid sponsored hires in similar roles
1 certified filing for “Clinical Lab Scientist I” (Medical and Clinical Laboratory Technologists) in CA: $86k–$86k, median $86k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

LOCATION: The territory for this position covers the Southeast region, including Mississippi, Alabama, Louisiana, Tennessee, and Georgia. POSITION SUMMARY The Clinical Oncology Specialist (COS) – Gastrointestinal (GI) is a high-impact, clinical sales role that leverages deep oncology, pathology, and molecular diagnostics expertise to drive the adoption and utilization of Natera's advanced oncology portfolio, with a primary focus on Signatera™ in GI malignancies (including Colorectal, Pancreatic, Esophageal, Gastric, and Hepatobiliary cancers ). As a crucial clinical partner, the COS will navigate complex, large academic health systems, NCI-designated cancer centers, and community clinics to bridge the gap between medical oncology, surgical oncology, and gastroenterology, ensuring seamless integration of Natera's testing into GI patient care pathways. The COS acts as a strategic collaborator across territories, working cross-functionally with internal oncology team members—including molecular sales specialists, pharma sales, and medical affairs—to formulate and execute unified strategic account plans. This is accomplished through high-level clinical dialogue, targeted provider education, and the implementation of efficient workflow processes for appropriate patient identification and post-surgical MRD monitoring. PRIMARY RESPONSIBILITIES • Navigate Academic & Clinical Ecosystems: Establish a strong presence within large academic health systems, complex cancer centers, and community oncology practices. Successfully engage GI Oncologists, Medical Oncologists, Surgical Oncologists, Colorectal Surgeons, and Pathologists to integrate Signatera into multidisciplinary GI tumor boards and clinical treatment pathways. • Drive GI Clinical Adoption: Execute targeted sales strategies and deliver approved clinical marketing messages to key opinion leaders (KOLs), physicians, and hospital stakeholders to influence test adoption and volume growth across GI tumor types (Colorectal, Pancreatic, Esophageal, Gastric, and Hepatobiliary) . • Cross-Functional Collaboration: Partner seamlessly with internal cross-functional oncology team members (including molecular sales specialists, pharma sales, and medical affairs) to align strategy, share insights, and maximize market penetration within the territory. • Market & Product Expertise: Maintain a commanding knowledge of Natera's products, services, and reimbursement landscape, as well as competitor offerings, molecular pathology trends, liquid biopsy advancements, and personalized medicine in the GI oncology space. • Account Workflow Optimization: Identify logistical and clinical barriers to testing within institutions; implement streamlined processes for GI patient identification, sample acquisition (tissue and blood-based ctDNA), and result delivery. • Account Management & Retention: Monitor, document, and report on existing business health, proactive competitive threats, and new market opportunities. Act as a clinical concierge to escalate and swiftly resolve client issues. • Ethical Compliance: Conduct all business, clinical discussions, and field interactions with the highest level of integrity, compliance, and transparency. QUALIFICATIONS • Education & Experience: Bachelor's degree with at least 5 years of direct oncology or molecular diagnostics experience (experience in GI oncology, colorectal surgery, or molecular testing preferred) OR an Associate degree with at least 7 years of direct oncology experience . • Market Knowledge: Deep, pre-existing knowledge of the local oncology market, including key institutional networks, NCI centers, and community GI oncology practices. • Clinical Acumen: Robust understanding of oncology molecular diagnostics, next-generation sequencing (NGS), l

Apply on company site ↗